TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Select Medical ( (SEM) ) has shared an update.
On November 24, 2025, Select Medical Holdings Corporation received a non-binding proposal from Robert A. Ortenzio, the company’s Executive Chairman and Co-Founder, to acquire all outstanding shares for $16.00 to $16.20 per share. The board’s disinterested members are reviewing the proposal with advisors, emphasizing their commitment to the best interests of the company and its shareholders. The outcome of this proposal remains uncertain, and further comments will be made only if necessary.
The most recent analyst rating on (SEM) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Select Medical stock, see the SEM Stock Forecast page.
Spark’s Take on SEM Stock
According to Spark, TipRanks’ AI Analyst, SEM is a Neutral.
Select Medical’s overall stock score is driven by strong earnings call results and moderate technical indicators. However, financial performance concerns, particularly high leverage and declining cash flow, weigh on the score. The valuation is fair, providing a balanced risk-reward profile.
To see Spark’s full report on SEM stock, click here.
More about Select Medical
Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. As of September 30, 2025, the company operated 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.
Average Trading Volume: 1,104,951
Technical Sentiment Signal: Sell
Current Market Cap: $1.73B
For an in-depth examination of SEM stock, go to TipRanks’ Overview page.